| Bioactivity | Lp-PLA2-IN-6 (compound 18), a tetracyclic pyrimidinone compound, is a potent Lp-PLA2 inhibitor with a pIC50 of 10.0 for rhLp-PLA2. Lp-PLA2-IN-6 has the potential for neurodegenerative related diseases research[1]. |
| Name | Lp-PLA2-IN-6 |
| CAS | 2637485-13-1 |
| Formula | C25H21F5N4O3 |
| Molar Mass | 520.45 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Qiong Xiao, et al. Tetracyclic pyrimidinone compounds, preparation method, composition and application thereof. CN112574221B. |
Lp-PLA2-IN-6
CAS: 2637485-13-1 F: C25H21F5N4O3 W: 520.45
Lp-PLA2-IN-6 (compound 18), a tetracyclic pyrimidinone compound, is a potent Lp-PLA2 inhibitor with a pIC50 of 10.0 for
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.